The present disclosure relates to a resveratrol delivery system having modified resveratrol composition wherein the active ingredient is stable colloidal resveratrol nanoparticles in unconjugated form. The said composition and its process thereof can be used in numerous applications for treatment of a mammal susceptible to or afflicted with insulin resistance, metabolic syndrome, aging, apoptosis, inflammation, stress resistance, cancer, cardiovascular disease, muscular dystrophy, low fertility rates or any combination thereof since the modified resveratrol composition has higher bioavailability and greater half-life.
